From: Cerebrospinal fluid penetration of fosfomycin in patients with ventriculitis: an observational study
Fosfomycin [g/24 h] | 20 ± 6 |
Fosfomycin therapy [d] | 13 ± 9 |
Fosfomycin CL [L/h] | 4.2 ± 2.2 |
Fosfomycin serum level [mg/L] first measurement | 209 [163–438] |
Fosfomycin CSF level [mg/L] first measurement | 104 [65–269] |
Fosfomycin serum level [mg/L]—all samples | 200 [159–289] |
Fosfomycin CSF level [mg/L]—all samples | 99 [66–144] |
Fosfomycin penetration rate [%] | 46 [36–59] |
Fosfomycin AUC in serum [mg*h/L] | 4800 [3816–7152] |
Fosfomycin AUC in CSF [mg*h/L] | 2381 [1586–3456] |
AUC/MIC (32 mg/L) ratio in serum | 150 [119–224] |
AUC/MIC (32 mg/L) ratio in CSF | 74 [50–108] |